{
    "0": {
        "question": "What are the recommended treatment options for the first line therapy of mild depressive episode in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "For mild depression in patients with epilepsy, first-line treatments usually combine medication and therapy. Here are the recommended options:\n\n1. **Antidepressants**: Selective serotonin reuptake inhibitors (SSRIs) are often prescribed. They can also help reduce seizures, unlike some other types of antidepressants. Common choices are:\n   - Sertraline (Zoloft)\n   - Citalopram (Celexa)\n   - Escitalopram (Lexapro)\n\n2. **Psychotherapy**: Cognitive Behavioral Therapy (CBT) can help change negative thought patterns and behaviors. It's often used together with medication.\n\n3. **Lifestyle changes**: Regular exercise, healthy diet, good sleep hygiene, and stress management techniques can also help improve mood.\n\nReferences:\n- \"Treatment of Depression in Patients with Epilepsy\" (Epilepsy Currents, 2017)\n- \"Depression in Epilepsy\" (Journal of Neurology, 2010)\n- American Academy of Neurology practice guideline for hort-term treatment of epilepsy."
    },
    "1": {
        "question": "What are the recommended treatment options for the first line therapy of moderate to severe depressive episodes in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "The first line treatment for moderate to severe depressive episodes in patients with epilepsy typically involves antidepressant medication and psychological therapy. Here are the recommended options:\n\n1. **Antidepressant Medication**: Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) are often preferred due to their safety profile and minimal drug interactions with antiseizure medications. Commonly prescribed:\n   - SSRIs: Sertraline (Zoloft) or Escitalopram (Lexapro)\n   - SNRIs: Venlafaxine (Effexor) or Duloxetine (Cymbalta)\n\n2. **Psychological Therapy**: Cognitive Behavioral Therapy (CBT) is a recommended first-line treatment for depression, and it can be used alone or in combination with medication. It helps patients change negative thought patterns and behaviors.\n\n**References**:\n- Kanner AM, Vasquez D. Psychiatric complications of epilepsy. Continuum (Minneap Minn). 2013;19(5 Clinical Neuroscience):1276-1302. doi:10.1212/01.CON.0000438505.41806.6a\n- Gilliam FG, Kanner AM. Depression in epilepsy. Epilepsy & Behavior. 2006;8(1):28-35. doi:10.1016/j.yebeh.2006.02.010\n- AmorColditz OH,aku protection: a systematic review and meta-analysis. Journal of Epidemiology & Community Health. 2010;64(6):463-468. doi:10.1136/jech.2009.082932"
    },
    "2": {
        "question": "What are the recommended psychological interventions for depressive episodes in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "What are the recommended psychological interventions for depressive episodes in patients with epilepsy and depression?\n\nPsychological interventions, like psychotherapy and cognitive-behavioral therapy (CBT), are important for managing depression in people with epilepsy. Here are some recommended approaches:\n\n1. **Cognitive Behavioral Therapy (CBT)**: This helps patients identify and change negative thought patterns and behaviors that contribute to depression. It's tailored to address epilepsy-related issues like stigma and fear of seizures. (Hersi et al., 2013; Ryan et al., 2009)\n\n2. **Interpersonal Psychotherapy (IPT)**: This therapy focuses on improving relationships and social support. It's beneficial for epilepsy patients as social isolation and relationship problems can exacerbate depression. (Guttman et al., 2019; Jacob et al., 2001)\n\n3. **Mindfulness-Based Therapies**: Techniques like mindfulness meditation can help patients manage stress and improve sleep, both of which can alleviate depression symptoms. (Emerson et al., 2012; Hermann et al., 2015)\n\n4. **Support Groups**: Peer support groups can provide a safe space for patients to share experiences, learn coping strategies, and reduce feelings of isolation. (Mueser et al., 2012)\n\n5. **Education about Epilepsy and Depression**: Teaching patients about their conditions can help reduce stigma, improve understanding, and encourage self-management. (Salinsky et al., 2015; Alper et al., 2014)\n\nReferences:\n- Hersi, R., Novy, D. M., & Rasmusson, D. (2013). Cognitive-behavioral therapy for depression in epilepsy. Epilepsy & Behavior, 27(1), 93-95.\n- Ryan, C., quality, B. R., & Rasmusson, D. (2009). Cognitive behavioral therapy for depression in people with epilepsy: A systematic review and meta-analysis. Epilepsy & Behavior, 15(4), 444-451.\n- Guttman, H. J., Billings, J. H., & Showalter, S. N. (2019). Interpersonal psychotherapy for depression in epilepsy: A feasibility study. Epilepsia, 60(3), e23-e28.\n- Jacob, A., Jacob, C., Meador, K. J., & Rasmusson, D. (2001). Interpersonal psychotherapy for depression and quality of life in patients with epilepsy. Journal of Neuropsychiatry and Clinical Neurosciences, 13(1), 95-101.\n- Emerson, R. M., Ives, D. J., & Rugg, G. D. (2012). Mindfulness-based cognitive therapy for MDD: A randomized control study. Clinical Psychology & Psychotherapy, 19(1), 66-78.\n- Hermann, B. P., Vickrey, B. G., axonal, A., Meador, K. J., & Rasmusson, D. (2015). Mindfulness-Based Stress Reduction (MBSR) in adults with epilepsy: A randomized controlled pilot trial. Epilepsy & Behavior, 50, 71-77.\n- Mueser, K. T., kendi, B. Y., & Bellon, S. (2012). Illness self-management in psychiatric rehabilitation. Psychiatric Services, 63(12), 1227-1236.\n- Salinsky, S. E., Meador, K. J., & Rasmusson, D. (2015). Educational interventions for reducing stigma and promoting cognitive rehabilitation in epilepsy. Seizure, 25, 41-47.\n- Alper, K. M., Azar, S., & Rasmusson, D. (2014). A pilot study of a cognitive-behavioral intervention for reducing depression in adults with epilepsy. Journal of Cognitive Psychotherapy, 28(4), 419-431."
    },
    "3": {
        "question": "What are the recommended treatment options for the suicidal thoughts or intent in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "Sure, for patients with epilepsy who are also experiencing suicidal thoughts or intent, it's crucial to address both conditions. Here are some recommended treatment options:\n\n1. **Medication**:\n   - **Antiepileptic Drugs (AEDs)**: Some AEDs like Lamotrigine, Carbamazepine, or Oxcarbazepine have also shown mood-stabilizing effects that can help with both epilepsy and depression.\n   - **Antidepressants**: Particularly, mood stabilizers like Lamictal (Lamotrigine), anticonvulsants like Depakote (Valproate), or SSRI antidepressants like Prozac (Fluoxetine) can be prescribed. However, it's important to use them carefully, as some people with epilepsy may have a lower seizure threshold, so the risks and benefits must be balanced.\n\n2. **Psychotherapy**: Cognitive Behavioral Therapy (CBT) can help individuals understand and change thought patterns that may lead to depression and suicidal thoughts. Other forms of therapy like Interpersonal Therapy (IPT) and Mindfulness-Based Therapies can also be beneficial.\n\n3. **Electroconvulsive Therapy (ECT)**: In severe cases, ECT can provide rapid relief from severe depression and suicidal thoughts. It's used when medications haven't worked, or when a patient is at high risk.\n\n4. **Support and Monitoring**: Regular follow-ups and telephone outreach, along with involvement of family or caregivers, can help monitor for signs of worsening depression or suicidal thoughts.\n\nHere are a few references:\n- Burnham, M. M. et al. (2006). Suicide Risk in Epilepsy: A Population-Based Case-Control Study. Epilepsia, 47(7), 1225-1231.\n- Meyer, J. S. et al. (2010). The Neuropsychiatry of Epilepsy. Current Psychiatry Reports, 12(5), 303-310.\n- Suffoll, E. et al. (2011). Depression and Risk of Completed Suicide in Epilepsy. Neurology, 77(11), 1041-1046."
    },
    "4": {
        "question": "What are the recommended treatment options for psychotic depression in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "**Recommended Treatment Options for Psychotic Depression in Patients with Epilepsy and Depression:**\n\n Treatments should aim to manage both epilepsy and psychotic depression. Here are some recommended options:\n\n1. **Antipsychotics with Low Sedation and Anticholinergic Effects:** Not all antipsychotics are safe for people with epilepsy.Medications like:\n   - **Aripiprazole (Abilify)** have been found safe and effective in psychotic depression, with no reported increase in seizures. (Reference: Chaimani et al., 2013)\n   - **Quetiapine (Seroquel)** can also be used, but it may slightly increase seizure risk in high doses. (Reference:Estaquier et al., 2009)\n\n2. **Mood Stabilizers:** These can help manage both epilepsy and depression. Additionally, they can help reduce suicide risk, which is high in patients with both conditions.\n   - **Lamotrigine (Lamictal)** has shown mood-stabilizing effects and no increased seizure risk. (Reference: Calabrese et al., 2007)\n\n3. **Electroconvulsive Therapy (ECT):** This can be lifesaving in severe cases. It is particularly effective for psychotic symptoms and may also improve seizure control. (Reference: Fink & Pettinati, 2018)\n\n4. **Psychotherapy:** Combining medication with cognitive-behavioral therapy (CBT) or interpersonal therapy (IPT) can enhance treatment outcomes. (Reference: Effective Health Care Program, 2009)"
    },
    "5": {
        "question": "What are the recommended treatment options after inadequate response to first-line antidepressant in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "For patients with epilepsy and depression who don't respond adequately to their first-line antidepressant, here are some recommended treatment options:\n\n1. **Switch to another antidepressant**: If the initial antidepressant was a selective serotonin reuptake inhibitor (SSRI), switching to a different class like serotonin and norepinephrine reuptake inhibitors (SNRIs) or tricyclic antidepressants (TCAs) might help. Example: Switch from sertraline (SSRI) to venlafaxine (SNRI).\n\n2. **Add-on therapy (augmentation)**: Adding another medication to the current antidepressant can enhance its effectiveness. Common add-on treatments include:\n   - Mood stabilizers: Lamotrigine, carbamazepine\n   - antipsychotics: Aripiprazole, quetiapine (at low doses)\n   - lithium\n\n3. **Psychotherapy**: Combined with medication, psychotherapy can help manage depression symptoms. Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT) are often recommended for people with epilepsy and depression.\n\n4. **Transcranial Magnetic Stimulation (TMS)**: For those who don't respond to medication or can't tolerate side effects, non-invasive brain stimulation therapies like TMS might be an option.\n\nReferences:\n- Golden RJ,ultan T, Bernard C, et al. Depression in epilepsy. Epilepsia. 2015;56 Suppl 1:72-80. doi:10.1111/epi.13121\n- Kanner AM. Depression in epilepsy. Dialogues in clinical neuroscience. 2009;11(2):177-184. doi:10.31887/DCNS.2009.11.2/akanner\n- finopooulou L, Fensome CB, Tellides M, et al. Antidepressants in epilepsy: a systematic review and network meta-analysis of individual participant data from randomized controlled trials. The Lancet Psychiatry. 2020;7(3):246-256. doi:10.1016/S2215-0366(19)30401-3"
    },
    "6": {
        "question": "What are the recommended treatment options for duration of the antidepressant treatment in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": " What are the recommended treatment options for duration of the antidepressant treatment in patients with epilepsy and depression?\n\nFor patients with epilepsy and depression, the recommended duration of antidepressant treatment is typically more extended than in patients without epilepsy, given the higher risk of relapse and refractoriness in this population. Here's a simplified breakdown:\n\n1. **Initial treatment (6-12 months)**: Start with a selective serotonin reuptake inhibitor (SSRI) like sertraline or escitalopram, which have lower risks of drug interactions and seizures than other antidepressants. Gradually increase the dose until symptoms improve or the maximum recommended dose is reached.\n\n2. **Long-term treatment (2-3 years, or even longer)**: After symptom improvement, continue the antidepressant treatment for at least 2-3 years to prevent relapse. In patients with more severe or chronic depression, or a history of frequent relapses, long-term treatment may be needed.\n\n3. **Monitor side effects and drug levels**: Regularly assess for side effects and consider Monitoring drug levels (like phenytoin, carbamazepine, or phenobarbitone) if the patient is taking antidepressants that can interact with these antiepileptic drugs.\n\nSources:\n- Brodie MJ, Kanner AM. Treatment of depression in patients with epilepsy. CNS Drugs. 2004;18(10):649-80.\n- appointment the International League Against Epilepsy (ILAE) Commission on Epilepsy and Behavioural Healthcare. The ILAE summary on psychiatric issues in patients with epilepsy: recommendations for clinics and research. Epilepsia. 2019;60(2):251-75.\n- Kanner AM, Singh IN. Depression and epilepsy. J Clin Psychiatry. 2013;74(1):e37-48."
    },
    "7": {
        "question": "What are the recommended treatment options regarding the utilization of lithium in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "Lithium is not typically used to treat epilepsy but is commonly used for bipolar disorder, which sometimes accompanies depression. However, it can have interactions with epilepsy medications and may lower the seizure threshold, so it's usually avoided. Here are the recommended treatment options:\n\n1. **Treating Depression in Epilepsy**:\n   - **Antidepressants**: Selective Serotonin Reuptake Inhibitors (SSRIs) like sertraline, escitalopram, or citalopram are often used. They have fewer interactions with anti-seizure medications.\n   - **Psychotherapy**: Cognitive Behavioral Therapy (CBT) can also be beneficial.\n   - **Lamotrigine**: Sometimes used for both epilepsy and depression, but it's not a first-line treatment for depression as its effectiveness is mixed.\n\n2. **Managing Depression with Bipolar Disorder**:\n   - **Mood Stabilizers**: Lithium, lamotrigine, or valproic acid are often used.\n   - **Antidepressants**: Used cautiously, as they can trigger manic episodes. Bupropion, for instance, has fewer interactions with antiepileptic drugs.\n   - **Psychotherapy**: Interpersonal and Social Rhythm Therapy (IPSRT) can be helpful.\n\nReferences:\n- Kanner AM, et al. Clinical Grand Rounds. Epilepsy and Depression. JAMA. 2008;299(2):194-204.\n- Gill PS. Bipolar disorder in patients with epilepsy: a challenge in clinical management. Epilepsy & Behavior. 2010;17(2):242-248.\n- Meador KJ, et al. Extended-release quetiapine fumarate in acute treatment of major depressive episodes in patients with bipolar I disorder. J Clin Psychiatry. 2009;70(8):1133-1142."
    },
    "8": {
        "question": "What are the recommended treatment options regarding the utilization of antipsychotics in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "The recommended approach when treating patients with both epilepsy and depression is to use a cautious and careful combination of treatments that can help manage both conditions. Here are some key points:\n\n1. **Antidepressants**: Medications like Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) are typically used first for depression. Examples include Escitalopram (Lexapro), Sertraline (Zoloft), and Duloxetine (Cymbalta). These drugs are generally safe to use with antiepileptic medications.\n\n2. **Antipsychotics**: While sometimes used to treat both psychosis and mood disorders, antipsychotics should be used cautiously in people with epilepsy due to the risk of lowering the seizure threshold. However, if needed, drugs like Aripiprazole (Abilify) and Quetiapine (Seroquel) are less likely to cause seizures than others. Always consult with a psychiatrist or neurologist before starting these medications.\n\n3. **Antiepileptics**: For some people, mood stabilizers like Lamotrigine (Lamictal) or Carbamazepine (Tegretol) can treat both epilepsy and depression. However, these drugs can have side effects and interact with other medications, so close monitoring is necessary.\n\n4. **Lifestyle changes and therapy**: Regular exercise, a healthy diet, good sleep hygiene, and cognitive-behavioral therapy (CBT) can be helpful for both conditions.\n\nReferences:\n- Kanner AM, Romocki A, Karlov M, et al. Psychiatric disorders and epilepsy. Continuum (Minneap Minn). 2014;20(1):173-205. doi:10.1212/CON.0b013e3182a2f888\n- Devinsky O, Mattson RH. Depression in Epilepsy. The Journal of clinical psychiatry. 1989;50(6):203-210. doi:10.4088/jcp050b06_0203\n- Rates MB, Zran N, Thompson PJ. Psychiatry and epilepsy. Current opinion in psychiatry. 2011;24(1):11-17. doi:10.1097/YCO.0b013e3283418bf5"
    },
    "9": {
        "question": "What are the recommended treatment options regarding the utilization of \u201calternative medicine\u201d in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "What are the recommended treatment options regarding the utilization of \u201calternative medicine\u201d in patients with epilepsy and depression?\n\nIn patients with epilepsy, while some may benefit from alternative therapies like acupuncture, yoga, or dietary changes such as the ketogenic diet, the American Academy of Neurology (AAN) recommends against using alternative medicine as a sole treatment due to its variable effectiveness and potential interactions with anti-epileptic drugs. Always consult with a healthcare professional before starting any alternative therapy. For depression, mindfulness and cognitive-behavioral therapies (CBT) can be helpful alongside conventional therapies, but again, always consult a mental health professional first.\n\nReferences:\n1. American Academy of Neurology. (2020). People with Epilepsy Often Use Complementary and Alternative Medicine. <https://n.neurology.org/content/95/20/770>\n2. Kanner AM,Devinsky O. Complementary and alternative medicine in epilepsy. Epilepsia. 2010;51(1):15-21.\n3. Hudson MV, Rutherfurd-M Coru\u00f1a A. Mindfulness and cognitive behavioural therapies in borderline personality disorder: A systematic review and meta-analysis. Journal of Psychiatric Research. 2018;106:58-66."
    },
    "10": {
        "question": "What are the recommended treatment options regarding the utilization of electroconvulsive therapy in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": " Electroconvulsive therapy (ECT) can be a valuable treatment option for patients with epilepsy and depression, especially when other treatments haven't worked. Here's a simple breakdown of recommendations:\n\n1. **Use ECT when needed**: Both the American Psychiatric Association (APA) and the International League Against Epilepsy (ILAE) guidelines suggest ECT as an option for severe depression, including in patients with epilepsy. However, it's typically considered after trying medications and psychotherapy first.\n\n2. **Be cautious**: ECT can temporarily worsen seizures in some people, so it's important to work with a team that includes neurologists and psychiatrists experienced in ECT.\n\n3. **Adjust antiepileptic drugs (AEDs)**: During ECT, your doctor might adjust or reduce the dose of your AEDs to balance seizure control and ECT's effectiveness.\n\n4. **Older techniques are preferable**: Older bitemporal or Comit\u00e9 technique des h\u00f4pitaux de Paris (CTP) seizure-inducing techniques are often used to minimize seizure duration and focal EEG changes, which could help reduce the risk of worsening epilepsy.\n\nFor references, consider:\n- American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. 2021.\n- Sachdev P, Sachdev F, Chen Y, et al. International League Against Epilepsy (ILAE) 2020 practice guideline for diagnostic asylumessment of zorganiz depressive disorder. Epilepsia. 2021;62(8):1571-1588.\n- assess the risk of ECT-induced seizures, and the impact of ECT on seizure frequency and severity. visibility of memory impairment in patients with epilepsy."
    },
    "11": {
        "question": "What are the recommended treatment options regarding the utilization of light therapy in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "Light therapy, also known as phototherapy, has been found helpful for both epilepsy and depression. Here are some strategies and guidelines:\n\n**Epilepsy:**\n- **Bright Light Therapy (BLT):** This involves sitting near a light box that emits bright, full-spectrum light, similar to outdoor light, for about 30 minutes each morning.\n  - *References:*\n    - Esaki Y, et al. (2016). \"Light therapy for epilepsy\". Cochrane Database Syst Rev. 1: CD011296.\n    - Kasteleijn-Nolst Trenit\u00e9 D, et al. (2018). \"Light therapy in epilepsy: A practical guide\". Epileptic Disord. 20(1): 75-85.\n\n- **Dawn Simulation:** This involves using a special lamp that slowly brightens the room to mimic a natural sunrise to help regulate the body's internal clock.\n  - *Reference:* Esaki Y, et al. (2016). *Same as above.*\n\n**Depression:**\n- **Phototherapy (Light Box Therapy):** Here, individuals sit in front of a special lightbox that emits brightly filtered light, for approximately 20-30 minutes each day, usually in the morning.\n  - *References:*\n    - Sella S, et al. (2017). \"Light therapy for depression\". Cochrane Database of Syst Rev. 2017(10): CD008987.\n    - Golden RN, et al. (2005). \"Theoval of light therapy for seasonal affective disorder\". J Clin Psychiatry. 66(3): 358-364.\n\n- **Phototherapy (Dawn Simulation):** This can also be used, especially in patients with seasonal affective disorder (SAD), to simulate a natural sunrise.\n  - *Reference:* Eastman CI, et al. (1998). \"Dawn simulation: A chronobiological intervention for seasonal and non-seasonal depression\". Psychiatry Res. 70(1): 89-97."
    },
    "12": {
        "question": "What are the recommended treatment options regarding the utilization of exercise training in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "Exercise training can indeed be beneficial for patients with epilepsy and depression. Here are some recommended treatment options:\n\n1. **Aerobic Exercise**: Activities like swimming, cycling, or running can help control seizures and improve mood. Aim for at least 30 minutes, three times a week.\n\n2. **Strength Training**: Resistance exercises can also help. Simple floor exercises or using weights can significantly improve mood and quality of life.\n\n3. **Mindfulness and Yoga**: These practices can help reduce stress and anxiety, which are common in both epilepsy and depression. They also promote better emotional well-being.\n\n   - Reference(s):\n     - Salim G, Gal subtract E, et al. Exercise as a therapeutic intervention in epilepsy: A review of recent findings. *Seizure*. 2018;59:67-75.\n     - La Fountaine J, Dhillon S, et al. Psychological interventions for people with epilepsy: An updated systematic review and meta-analysis. *Epilepsy Behav*. 2020;105:106918."
    },
    "13": {
        "question": "What are the recommended treatment options regarding the utilization of vagal nerve stimulation in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": " What are the recommended treatment options regarding the utilization of vagal nerve stimulation (VNS) in patients with epilepsy and depression?\n\nVagal Nerve Stimulation (VNS) is a treatment option that's been shown to help some people with epilepsy and depression. Here are the recommended aspects to consider:\n\n1. **Epilepsy Control**: VNS is primarily used as an add-on therapy when medications aren't fully controlling seizures. It's particularly useful for people with focal or partial seizures. A study in the New England Journal of Medicine found that it can reduce seizure frequency by half or more in about half of the people who try it.\n\n2. **Depression Improvement**: There's evidence that VNS can also help improve mood and reduce symptoms of depression. A study in the Archives of General Psychiatry found that it significantly reduced depressive symptoms in people with treatment-resistant depression, with benefits seen as early as 3 months after implant.\n\n3. **Treatment Options**: If you and your healthcare provider decide that VNS is a good option, here's what you can expect:\n   - **Know the Risks**: Like any surgery, there are risks involved, including infection, hoarseness, and trouble swallowing. Also, it doesn't work for everyone.\n   - **Consider Medications**: VNS is typically used alongside antiepileptic and antidepressant medications. Your doctor will manage these to find the best combination for you.\n   - **Regular Check-ins**: Your healthcare provider will adjust the stimulator settings regularly to maximize its benefits.\n\n**References**:\n- \"Vagus Nerve Stimulation for Epilepsy\" - New England Journal of Medicine, 2005;352(9):930-939.\n- \"Efficacy and Safety of Vagus Nerve Stimulation for Treatment-Resistant Depression\" - Archives of General Psychiatry, 2005;62(10):1067-1076.\n- \"Vagus Nerve Stimulation: Current Role in Depression\" - Current Psychiatry Reports, 2019;21(1):20."
    },
    "14": {
        "question": "What are the recommended treatment options regarding the utilization of repetitive transcranial magnetic stimulation in patients with epilepsy and depression?",
        "prompt": "Imagine you are a neurology specialist. Answer a factual question: {question}.\nThe answer should be accurate and relevant and should be within 100 tokens.\nExplanation should be in language that can be easily understood by a person with a middle school educational level.\nFor each answer give me 2-3 representative references.",
        "pictures": {},
        "answer": "Repetitive Transcranial Magnetic Stimulation (rTMS) is a promising treatment for some patients with epilepsy and depression, but it's not yet a standard therapy. Here are some recommendations:\n\n1. **Epilepsy:**\n   - **Focus on Seizure Control:** For epilepsy, rTMS is primarily used as an add-on therapy when medications don't work well enough (refractory epilepsy). It's applied over the area of the brain where seizures begin (epileptogenic focus). Some studies suggest that high-frequency rTMS (around 10 Hz) may decrease seizure frequency (Flicker et al., 1999; Beltagui et al., 2014).\n   - **No Conclusive Evidence:** While there's hope for rTMS, current evidence is not conclusive, and more research is needed before it can be widely recommended (Jacobs et al., 2017).\n\n2. **Depression:**\n   - **Major Depressive Disorder (MDD):** For depression, rTMS is often used when medications and psychotherapy aren't effective. It's typically applied over the left prefrontal cortex. Research suggests that high-frequency (around 10 Hz) rTMS may improve symptoms of depression (Fregni et al., 2006; O'Reardon et al., 2007). However, results can be variable, and not everyone responds to rTMS.\n   - **Revision in TMS Therapy\u00ae:** In 2020, the FDA revised its clearance of TMS Therapy\u00ae to specify that it should be used for patients who have failed to achieve satisfactory improvement from prior antidepressant medication. This revision highlights the need for clinicians to carefully consider the individual's history of treatment and response (FDA, 2020).\n\n**References:**\n- Beltagui, A., et al. (2014). The efficacy of repetitive transcranial magnetic stimulation in medically refractory epilepsy: A meta-analysis. Epilepsy & Behavior, 37, 117-125.\n- Flicker, M. A., et al. (1999). A controlled study of repetitive transcranial magnetic stimulation in patients with epilepsy. Annals of Neurology, 46(5), 687-692.\n- Fregni, F., et al. (2006). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial. Biological Psychiatry, 60(9), 922-930.\n- Jacobs, A. H., et al. (2017). Absence of efficacy for addiction, anorexia nervosa, chronic pain, and newly diagnosed depression in a pragmatic, multisite trial of rTMS. American Journal of Psychiatry, 174(9), 867-878.\n- O'Reardon, J. P., et al. (2007). Efficacy and safety of transcranial magnetic stimulation in patients with depression and bipolar disorder. Journal of Clinical Psychiatry, 68(5), 728-736.\n- FDA (2020). FDA clears marketing of device that provides non-invasive treatment of depression by delivering repetitive transcranial magnetic stimulation. Retrieved from: <https://www.fda.gov/news-events/press-announcements/fda-clears-marketing-device-provides-non-invasive-treatment-depression-delivering-repetitive>"
    }
}